Antares Pharma Inc (ATRS.OQ)
4.39USD
10:56am EDT
$-0.03 (-0.68%)
$4.42
$4.44
$4.45
$4.38
31,161
198,839
$4.86
$3.35
About
Overall
| Beta: | 0.70 |
| Market Cap (Mil.): | $557.70 |
| Shares Outstanding (Mil.): | 126.18 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ATRS.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 27.50 | 37.76 |
| EPS (TTM): | -0.13 | -- | -- |
| ROI: | -25.15 | 9.26 | 18.76 |
| ROE: | -25.52 | 12.54 | 19.59 |
UPDATE 1-New U.S. rocket blasts off from Virginia launch pad
* Antares rocket carries dummy cargo capsule on test flight
New U.S. rocket blasts off from Virginia launch pad
- A privately owned rocket built in partnership with NASA to haul cargo to the International Space Station blasted off on Sunday for a debut test flight from a new commercial spaceport in Virginia.
New U.S. rocket blasts off from Virginia launch pad
* Antares rocket carries dummy cargo capsule on test flight
New U.S. rocket cleared for test flight from Virginia spaceport
CAPE CANAVERAL, Florida - A second U.S. company hired by NASA to fly cargo to the International Space Station was cleared to test-fly its Antares rocket from a newly developed commercial spaceport in Virginia, officials said on Tuesday.
New U.S. rocket cleared for test flight from Virginia spaceport
CAPE CANAVERAL, Fla., April 16 - A second U.S. company hired by NASA to fly cargo to the International Space Station was cleared to test-fly its Antares rocket from a newly developed commercial spaceport in Virginia, officials said on Tuesday.
Competitors
| Price | Change | |
|---|---|---|
| Astellas Pharma Inc (4503.T) | ¥5,340 | +90.00 |
| Pfizer Inc. (PFE.N) | $29.16 | -0.07 |
| Novo Nordisk A/S (NOVOb.CO) | kr.975.00 | +27.00 |
| Merck & Co., Inc. (MRK.N) | $48.06 | -0.11 |
| Roche Holding Ltd. (ROG.VX) | CHF228.00 | -3.50 |
| Abbott Laboratories (ABT.N) | $36.89 | +0.26 |
| GlaxoSmithKline plc (GSK.L) | 1,705.00p | +21.00 |
| Eli Lilly & Co. (LLY.N) | $53.22 | +0.11 |
| Teva Pharmaceutical Industries Limited (TEVA.TA) | 13,920.00₪ | -200.00 |
| Becton, Dickinson and Co. (BDX.N) | $102.75 | -0.97 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Jefferson Research
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

